Alex F. Herrera

机构：City Of Hope National Medical Center, City of Hope · ORCID：0000-0002-9665-7415

发表论文 565 篇 · 总被引 12268 次 · h-index 48

代表论文

• Real-world outcomes for lisocabtagene maraleucel in patients with relapsed or refractory large B-cell lymphoma (2026 · Blood · 被引 3)
• LymphGen-Sig: Integrating genetic and transcriptional states to predict therapeutic response in DLBCL (2026 · medRxiv · 被引 1)
• Impact of EBV Status and Histology on Patient Outcomes with Nivolumab-AVD vs BV-AVD in Advanced Classic Hodgkin Lymphoma (S1826) (2026 · Blood Advances)
• Low lymphoma macrophage infiltration predicts poor outcomes in R-CHOP- but not Pola-R-CHP-treated patients with DLBCL (2026 · Blood Neoplasia)
• Real-World Outcomes of Mosunetuzumab Use in Relapsed/Refractory Indolent Lymphomas: A CUBIC Consortium Analysis (2026 · Blood Neoplasia)
• Nivolumab in combination with AVD as frontline treatment for patients with classic Hodgkin lymphoma: A real-world analysis from 20 US centers. (2026 · UNC Libraries)